LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 36 of 497
Next
>>
>
876 to 900 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Lapatinib	0.37	uM	LJP6	3	M22	72	hr	1657	5301	5505	0.9628	0.9468
BT-20	LDN-193189	0.37	uM	LJP5	1	G04	72	hr	1657	5337	5505	0.9694	0.9562
BT-20	LDN-193189	0.37	uM	LJP5	2	G04	72	hr	1657	5524	5505	1.0033	1.0048
BT-20	LDN-193189	0.37	uM	LJP5	3	G04	72	hr	1657	5355	5505	0.9726	0.9608
BT-20	Linifanib	0.37	uM	LJP6	1	J10	72	hr	1657	6107	5505	1.1092	1.1563
BT-20	Linifanib	0.37	uM	LJP6	2	J10	72	hr	1657	5698	5505	1.0349	1.0500
BT-20	Linifanib	0.37	uM	LJP6	3	J10	72	hr	1657	5760	5505	1.0462	1.0661
BT-20	Linsitinib	0.37	uM	LJP5	1	O22	72	hr	1657	4748	5505	0.8624	0.8031
BT-20	Linsitinib	0.37	uM	LJP5	2	O22	72	hr	1657	5180	5505	0.9409	0.9154
BT-20	Linsitinib	0.37	uM	LJP5	3	O22	72	hr	1657	5048	5505	0.9169	0.8811
BT-20	Mitoxantrone	0.37	uM	LJP5	1	C22	72	hr	1657	1621	5505	0.2944	-0.0095
BT-20	Mitoxantrone	0.37	uM	LJP5	2	C22	72	hr	1657	1690	5505	0.3070	0.0084
BT-20	Mitoxantrone	0.37	uM	LJP5	3	C22	72	hr	1657	1869	5505	0.3395	0.0549
BT-20	Mitoxantrone	0.37	uM	LJP6	1	C22	72	hr	1657	1763	5505	0.3202	0.0274
BT-20	Mitoxantrone	0.37	uM	LJP6	2	C22	72	hr	1657	1714	5505	0.3113	0.0146
BT-20	Mitoxantrone	0.37	uM	LJP6	3	C22	72	hr	1657	1681	5505	0.3053	0.0060
BT-20	MK2206	0.37	uM	LJP6	1	F04	72	hr	1657	3651	5505	0.6631	0.5180
BT-20	MK2206	0.37	uM	LJP6	2	F04	72	hr	1657	4069	5505	0.7391	0.6266
BT-20	MK2206	0.37	uM	LJP6	3	F04	72	hr	1657	4228	5505	0.7679	0.6680
BT-20	Neratinib	0.37	uM	LJP5	1	A16	72	hr	1657	4008	5505	0.7280	0.6108
BT-20	Neratinib	0.37	uM	LJP5	2	A16	72	hr	1657	4336	5505	0.7876	0.6960
BT-20	Neratinib	0.37	uM	LJP5	3	A16	72	hr	1657	4388	5505	0.7970	0.7095
BT-20	Nilotinib	0.37	uM	LJP5	1	N16	72	hr	1657	5443	5505	0.9886	0.9837
BT-20	Nilotinib	0.37	uM	LJP5	2	N16	72	hr	1657	5824	5505	1.0578	1.0827
BT-20	Nilotinib	0.37	uM	LJP5	3	N16	72	hr	1657	5273	5505	0.9577	0.9395

|<
<<
Previous
Page 36 of 497
Next
>>
>
876 to 900 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)